About Marco Pappagallo
Marco Pappagallo is CMO and director at NK-One Therapeutics.
Experience
This experience comes from Marco Pappagallo's profile and from SEC filings. For roles taken from filings, the years are when the filings name Marco Pappagallo in the role, so the role may have started earlier or lasted longer.
NK-One Therapeutics, Inc. Current
CMO and director
Chief Medical Officer (2026 – Present)
2026 – Present · Wayne, PA
Develops targeted treatments for people with chronic pain.
HC
https://nk1thera.com/ Current
Co-Founder - Board Director
2026 – Present
WC
www.levomecor.com Current
Scientific Advisor
2026 – Present
NL
NeuroArbor LLC Current
Scientific Advisor
2025 – Present
LI
LEVOMECOR INC. Current
Scientific Advisor
2025 – Present
PT
Psy Therapeutics Current
Scientific Advisor
2024 – Present
FP
FIORELLA NEUROLOGY, PC Current
Director
2012 – Present
RI
Relmada Therapeutics, Inc
Chief Medical Officer
2021 – 2023
CI
CERSCI THERAPEUTICS, INC.
Chief Medical Officer
2018 – 2020
GI
GRUNENTHAL USA, INC.
Medical Specialist
2011 – 2017
NI
NOVAPHARM THERAPEUTICS, INC.
Founder
2010 – 2012
Key Colleagues at Startups
The people Marco Pappagallo works with at each company, as listed on that company's latest Form D.
NK-One Therapeutics, Inc. · Form D, Apr 27, 2026
MS
Michael Shine
CEO and director